A5057178151- Renal cell carcinoma treatment
- Bladder and Urothelial Cancer Treatments
- Renal and Vascular Pathologies
- Ureteral procedures and complications
- Urological Disorders and Treatments
- Pelvic floor disorders treatments
- Pediatric Urology and Nephrology Studies
- Renal and related cancers
- Radiomics and Machine Learning in Medical Imaging
- Urinary Bladder and Prostate Research
- Organ Donation and Transplantation
- Prostate Cancer Diagnosis and Treatment
- Urinary and Genital Oncology Studies
- Kidney Stones and Urolithiasis Treatments
- Testicular diseases and treatments
- Urologic and reproductive health conditions
- Cancer Genomics and Diagnostics
- Multiple and Secondary Primary Cancers
- Spinal Dysraphism and Malformations
- Hernia repair and management
- Advanced X-ray and CT Imaging
- Sexual Differentiation and Disorders
- Artificial Intelligence in Healthcare and Education
- Prostate Cancer Treatment and Research
- Genital Health and Disease
Centre Hospitalier Universitaire de Rennes
2016-2025
European Association of Urology
2025
The University of Texas Southwestern Medical Center
2023-2025
Université de Rennes
2015-2025
Inserm
2018-2025
Southwestern Medical Center
2023-2025
Hôpital Pontchaillou
2015-2024
Laboratoire Traitement du Signal et de l'Image
2021-2024
Onco Lille
2024
Lymphoma Study Association
2022
To assess the impact of hospital volume (HV) and surgeon (SV) on perioperative outcomes robot-assisted partial nephrectomy (RAPN).All consecutive patients who underwent a RAPN from 2009 to 2015, at 11 institutions, were included in retrospective study. evaluate HV, we divided into four quartiles according caseload per year: low HV (<20/year), moderate (20-44/year), high (45-70/year), very (>70/year). The SV was also quartiles: (<7/year), (7-14/year), (15-30/year), (>30/year). primary...
Current literature does not provide large-scale data regarding clinical outcomes of robot-assisted (RAPN) versus open (OPN) partial nephrectomy. Moreover, assessing predictors long-term oncologic after RAPN are scarce.To compare perioperative, functional, and OPN, to investigate the RAPN.This study included 3467 patients treated with OPN (n = 1063) or 2404) for a single cT1-2N0M0 renal mass from 2004 2018 at nine high-volume European, North American, Asian institutions.The were short-term...
Objectives: To identify correlates of survival and perioperative outcomes upper tract urothelial carcinoma (UTUC) patients undergoing open (ORNU), laparoscopic (LRNU), robotic (RRNU) radical nephroureterectomy (RNU). Methods: We conducted a retrospective, multicenter study that included non-metastatic UTUC who underwent RNU between 1990–2020. Multiple imputation by chained equations was used to impute missing data. Patients were divided into three groups based on their surgical treatment...
Patients with intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC) are recommended to receive induction intravesical chemotherapy or immunotherapy. However, the comparison between gemcitabine and BCG in treatment-naive, low-grade IR-NMIBC patients remains underexplored. This study aims evaluate efficacy of compared a cohort treatment-naive patients. A retrospective analysis was conducted on low grade IR-NMIBC, classified according International Bladder Cancer Group criteria, no...
Radical cystectomy is the gold standard technique for muscle-invasive bladder cancer and resistant non cancer. This surgery presents a high rate of complications despite advance robotic surgery. The aim this study to compare according presence ureteral stents or not. 200 consecutive patients who underwent radical at our center between 2012 2022 were included in retrospective study. Cessation upper tract drainage was introduced prospectively February 2021, without any selection bias. Patients...